Terms: = Kidney tumors AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
21 results:
1. [Robot-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction].
Kurbanov AA; Kryukov SR; Chernov DV; Votyakov AY; Shpot EV
Urologiia; 2023 Sep; (4):125-128. PubMed ID: 37850292
[TBL] [Abstract] [Full Text] [Related]
2. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
[TBL] [Abstract] [Full Text] [Related]
3. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
4. Revisiting immunological and clinical aspects of membranous nephropathy.
Nieto-Gañán I; Iturrieta-Zuazo I; Rita C; Carrasco-Sayalero Á
Clin Immunol; 2022 Apr; 237():108976. PubMed ID: 35276323
[TBL] [Abstract] [Full Text] [Related]
5. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy.
Lai Y; Tang F; Huang Y; He C; Chen C; Zhao J; Wu W; He Z
J Cell Physiol; 2021 Mar; 236(3):1616-1627. PubMed ID: 32783202
[TBL] [Abstract] [Full Text] [Related]
6. The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells.
Patergnani S; Guzzo S; Mangolini A; dell'Atti L; Pinton P; Aguiari G
Exp Cell Res; 2020 Oct; 395(1):112190. PubMed ID: 32717219
[TBL] [Abstract] [Full Text] [Related]
7. [Hemoglobin drop after thrombolytic therapy in a 57-year-old stroke patient with "erosive gastritis"].
Vogel Y; Schulte-Fischedick A; Bauer H; Zobel C; Zienkiewicz T; Pinsdorf T
Internist (Berl); 2020 Jul; 61(7):746-753. PubMed ID: 32533196
[TBL] [Abstract] [Full Text] [Related]
8. [Surgical treatment of intracaval tumor relapse after radical tumor nephrectomy in locally advanced renal cell carcinoma].
von Zehmen T; Eich C; Fries J; von Brandenstein M; Pfister D; Heidenreich A
Urologe A; 2020 Oct; 59(10):1217-1224. PubMed ID: 32514706
[TBL] [Abstract] [Full Text] [Related]
9. Various forms of HIF-1α protein characterize the clear cell renal cell carcinoma cell lines.
Swiatek M; Jancewicz I; Kluebsoongnoen J; Zub R; Maassen A; Kubala S; Udomkit A; Siedlecki JA; Sarnowski TJ; Sarnowska E
IUBMB Life; 2020 Jun; 72(6):1220-1232. PubMed ID: 32250548
[TBL] [Abstract] [Full Text] [Related]
10. Thyroid follicular carcinoma-like renal tumor: A case report and literature review.
Zhang Y; Yang J; Zhang M; Meng Z; Song W; Yang L; Li L; Wang D; Shi T
Medicine (Baltimore); 2018 May; 97(21):e10815. PubMed ID: 29794767
[TBL] [Abstract] [Full Text] [Related]
11. Thyroid-like follicular carcinoma of the kidney: one case report and review of the literature.
Dawane R; Grindstaff A; Parwani AV; Brock T; White WM; Nodit L
Am J Clin Pathol; 2015 Nov; 144(5):796-804. PubMed ID: 26486745
[TBL] [Abstract] [Full Text] [Related]
12. [THE CURRENT APPROACH TO METASTATIC RENAL CELL CARCINOMA].
Keizman D; Maimon N; Mishaeli M; Kuchuk I; Gottfried M
Harefuah; 2015 Aug; 154(8):535-9. PubMed ID: 26480622
[TBL] [Abstract] [Full Text] [Related]
13. Haematuria: from identification to treatment.
King K; Steggall M
Br J Nurs; 2014 May 8-21; 23(9):S28-32. PubMed ID: 24820511
[TBL] [Abstract] [Full Text] [Related]
14. Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science.
Porta C; Sabbatini R; Procopio G; Paglino C; Galligioni E; Ortega C
Expert Rev Anticancer Ther; 2012 Dec; 12(12):1571-7. PubMed ID: 23181412
[TBL] [Abstract] [Full Text] [Related]
15. Non-functioning parathyroid gland carcinoma: case report.
Krvavica A; Kovacić M; Baraka I; Rudić M
Acta Clin Croat; 2011 Jun; 50(2):233-7. PubMed ID: 22263388
[TBL] [Abstract] [Full Text] [Related]
16. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
Bai L; Yang JC; Ok JH; Mack PC; Kung HJ; Evans CP
Int J Cancer; 2012 Jun; 130(11):2693-702. PubMed ID: 21792888
[TBL] [Abstract] [Full Text] [Related]
17. Phase II study of troxacitabine (bch-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
Townsley CA; Chi K; Ernst DS; Belanger K; Tannock I; Bjarnason GA; Stewart D; Goel R; Ruether JD; Siu LL; Jolivet J; McIntosh L; Seymour L; Moore MJ;
J Clin Oncol; 2003 Apr; 21(8):1524-9. PubMed ID: 12697876
[TBL] [Abstract] [Full Text] [Related]
18. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
[TBL] [Abstract] [Full Text] [Related]
20. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A; Scheulen ME; Schmoll HJ; Gründel O; Harstrick A; Knoche M; Fels LM; Skorzec M; Bach F; Baumgart J; Sass G; Seeber S; Thiel E; Berdel WE
Clin Cancer Res; 1998 Nov; 4(11):2701-8. PubMed ID: 9829732
[TBL] [Abstract] [Full Text] [Related]
[Next]
